PLSE
Pulse Biosciences Inc

2,033
Mkt Cap
$1.53B
Volume
284,863.00
52W High
$26.30
52W Low
$12.56
PE Ratio
-20.84
PLSE Fundamentals
Price
$22.40
Prev Close
$22.51
Open
$22.18
50D MA
$18.12
Beta
1.45
Avg. Volume
602,196.55
EPS (Annual)
-$1.08
P/B
18.93
Rev/Employee
$3,017.24
$852.13
Loading...
Loading...
News
all
press releases
Pulse Biosciences (NASDAQ:PLSE) Stock Price Passes Above Fifty Day Moving Average - What's Next?
Pulse Biosciences (NASDAQ:PLSE) Stock Price Crosses Above 50-Day Moving Average - Here's What Happened...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA), today announced a new strategic alignment to prioritize and...
Business Wire·2d ago
News Placeholder
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse Technology
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced first patient...
Business Wire·7d ago
News Placeholder
Pulse Biosciences (NASDAQ:PLSE) Trading 8% Higher - What's Next?
Pulse Biosciences (NASDAQ:PLSE) Shares Up 8% - Should You Buy...
MarketBeat·9d ago
News Placeholder
Pulse Biosciences Announces Clinical Data From nPulse Vybrance System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced clinical data on...
Business Wire·10d ago
News Placeholder
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced plans to...
Business Wire·14d ago
News Placeholder
Pulse Biosciences nPulse Vybrance System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced its nPulse...
Business Wire·15d ago
News Placeholder
Pulse Biosciences (NASDAQ:PLSE) Stock Passes Above 50 Day Moving Average - Should You Sell?
Pulse Biosciences (NASDAQ:PLSE) Shares Cross Above 50-Day Moving Average - Here's Why...
MarketBeat·15d ago
News Placeholder
Kevin Patrick Danahy Sells 5,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock
Pulse Biosciences, Inc (NASDAQ:PLSE - Get Free Report) insider Kevin Patrick Danahy sold 5,000 shares of the company's stock in a transaction on Wednesday, February 18th. The shares were sold at an...
MarketBeat·24d ago
News Placeholder
Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded Pulse Biosciences from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·27d ago
<
1
2
...
>

Latest PLSE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.